Literature DB >> 3888909

Growth characteristics of clonal cell populations constituting a B16 melanoma metastasis model system.

C W Stackpole, A L Alterman, D M Fornabaio.   

Abstract

Three distinct dissemination-related phenotypes have been distinguished among cell subpopulations of the mouse B16 melanoma: tumorigenicity, spontaneous metastasis from subcutaneous tumors, and organ colonization following intravenous injection of cells. From a progenitor clone (G3) of tumorigenic but nonmetastatic and noncolonizing (null) cells that underwent phenotypic diversification in vitro and in vivo, 4 subclones were obtained: G3.5 (culture-generated metastatic), G3.12 (tumor-generated metastatic), G3.15 (culture-generated null), and G3.26 (tumor-generated colonizing). The growth potentials of the parent clone and derived subclones were investigated comparatively in in vivo assays (tumorigenicity, tumor growth rate, and lung colonization potential), monolayer culture assays (generation time, saturation density, clonogenicity, and rate of detachment by trypsin), and in soft agar. In overall growth potential, G3.26 greater than G3.12 greater than G3, G3.5 greater than G3.15. These results indicate that metastatic populations of the B16 melanoma are not the most rapidly and effectively growing cells obtainable from that tumor.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3888909

Source DB:  PubMed          Journal:  Invasion Metastasis        ISSN: 0251-1789


  16 in total

1.  B16 melanoma spontaneous brain metastasis: occurrence and development within leptomeninges blood vessels.

Authors:  A L Alterman; C W Stackpole
Journal:  Clin Exp Metastasis       Date:  1989 Jan-Feb       Impact factor: 5.150

Review 2.  Technical considerations for studying cancer metastasis in vivo.

Authors:  D R Welch
Journal:  Clin Exp Metastasis       Date:  1997-05       Impact factor: 5.150

3.  Functional interactions between tumor and peripheral nerve: morphology, algogen identification, and behavioral characterization of a new murine model of cancer pain.

Authors:  P W Wacnik; L J Eikmeier; T R Ruggles; M L Ramnaraine; B K Walcheck; A J Beitz; G L Wilcox
Journal:  J Neurosci       Date:  2001-12-01       Impact factor: 6.167

4.  Induction of heat shock protein 27 by hydroxyurea and its relationship to experimental metastasis.

Authors:  A E Eskenazi; J Powers; J Pinkas; S Oesterreich; S A Fuqua; C N Frantz
Journal:  Clin Exp Metastasis       Date:  1998-04       Impact factor: 5.150

5.  An autologous oral DNA vaccine protects against murine melanoma.

Authors:  R Xiang; H N Lode; T H Chao; J M Ruehlmann; C S Dolman; F Rodriguez; J L Whitton; W W Overwijk; N P Restifo; R A Reisfeld
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

6.  Endothelial cell Ca2+ increases upon tumor cell contact and modulates cell-cell adhesion.

Authors:  R Pili; S Corda; A Passaniti; R C Ziegelstein; A W Heldman; M C Capogrossi
Journal:  J Clin Invest       Date:  1993-12       Impact factor: 14.808

7.  B16 melanoma variants selected by one or more cycles of spontaneous metastasis to the same organ fail to exhibit organ specificity.

Authors:  C W Stackpole; A L Alterman; E F Valle
Journal:  Clin Exp Metastasis       Date:  1991 May-Jun       Impact factor: 5.150

8.  Acquisition of in vitro growth autonomy during B16 melanoma malignant progression is associated with autocrine stimulation by transferrin and fibronectin.

Authors:  C W Stackpole; S S Kalbag; L Groszek
Journal:  In Vitro Cell Dev Biol Anim       Date:  1995-03       Impact factor: 2.416

9.  A murine model for bone marrow metastasis established by an i.v. injection of C-1300 neuroblastoma in A/J mice.

Authors:  M Iwakawa; K Ando; H Ohkawa; S Koike; Y J Chen
Journal:  Clin Exp Metastasis       Date:  1994-05       Impact factor: 5.150

10.  Failure of orally administered RA233 to influence B16 melanoma growth or metastasis.

Authors:  C W Stackpole; D M Fornabaio; A L Alterman
Journal:  Clin Exp Metastasis       Date:  1987 Apr-Jun       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.